James F III Oliviero
CIK 1434718 · CEO, President and Director · last filed 2025-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$940.6K
Companies
3
Total Filings
66
Lifetime Open-Market Net
-$15.03M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NVCT | Director | 87,828 | $10.71 | $940.6K | $0 | 4 | 2025-06-12 |
| Checkpoint Therapeutics, Inc. (CKPT) Delisted | CEO, President and Director | 0 | $4.26 | $0 | -$4.34M | 22 | 2025-05-30 |
| KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Chief Financial Officer | 209,406 | — | — | -$10.69M | 39 | 2015-07-08 |
Recent Filings · Page 4 of 7
66 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-01-06 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Mixed | +18,271 | -$77.3K | EDGAR |
| 2014-12-12 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Mixed | — | -$111.8K | EDGAR |
| 2014-10-07 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Sell (S) | −2,694 | -$43.5K | EDGAR |
| 2014-09-10 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Sell (S) | −144,237 | -$2.29M | EDGAR |
| 2014-07-09 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Sell (S) | −2,054 | -$32.4K | EDGAR |
| 2014-03-21 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Mixed | −188,444 | -$4.06M | EDGAR |
| 2014-01-06 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Mixed | +16,432 | -$79.3K | EDGAR |
| 2013-12-31 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Mixed | −79,500 | -$1.25M | EDGAR |
| 2013-10-07 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Sell (S) | −1,475 | -$15.1K | EDGAR |
| 2013-07-09 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Sell (S) | −1,438 | -$11.4K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.